# Dr Reddy's Laboratories Limited (NYSE: RDY), Srikakulam, India – FDA Inspections

Source: https://www.keypedia.com/companies/dr-reddys-laboratories-limited/97f3d461-62f0-4198-9e9d-7f7c7d43af86

> Inspection records and compliance data for Dr Reddy's Laboratories Limited in Srikakulam. 7 FDA inspections on record, 4 Form 483s, last inspected December 12, 2025. Publicly traded as NYSE: RDY.

---

## Details

- Name: Dr Reddy's Laboratories Limited
- FEI Number: 3009193040
- Facility Type: Dosage Drug Products
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, IN VITRO BIOEQUIVALENCE OR BIOANALYTICAL TESTING, PACK
- Address Line 1: FTO-Sez Process Unit-01, Survey No 57 to 59,60,62&72, Sector No 9 to 14 & 17 to 20,, Devunipalavalasa Village Ranasthalam(M)
- City: Srikakulam
- Country Name: India
- Address: FTO-Sez Process Unit-01, Survey No 57 to 59,60,62&72, Sector No 9 to 14 & 17 to 20,, Devunipalavalasa Village Ranasthalam(M), Srikakulam, India
- Country: India

## Stock

- Stock ticker: RDY
- Exchange: NYSE
- Share price: $14.73
- Market cap: $12.3B
- Price as of: November 13, 2026

## Related Documents

- [483 - Dr Reddy's Laboratories Limited - 2025-12-12](https://www.keypedia.com/records/483/dr-reddys-laboratories-limited/6491967a-9293-4c22-a75d-d79206e1088e) — source: FDA, date: December 12, 2025
- [FDA Inspection 1297022 - Dr Reddy's Laboratories Limited - 2025-12-12](https://www.keypedia.com/records/fda_inspections/dr-reddys-laboratories-limited/e4855c78-57b2-4e55-8e66-7cb13258b428) — source: FDA, date: December 12, 2025
- [483 - Dr Reddy's Laboratories Limited - 2024-08-23](https://www.keypedia.com/records/483/dr-reddys-laboratories-limited/4ebd243f-4c5b-43ea-afa9-7af5a36b491a) — source: FDA, date: August 23, 2024
- [FDA Inspection 1250569 - Dr Reddy's Laboratories Limited - 2024-08-23](https://www.keypedia.com/records/fda_inspections/dr-reddys-laboratories-limited/095f69c8-460c-483b-80ad-230b8c63ba1a) — source: FDA, date: August 23, 2024
- FDA Inspection 1230622 - Dr Reddy's Laboratories Limited - 2022-05-20 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 20, 2022
- FDA Inspection 1122262 - Dr Reddy's Laboratories Limited - 2020-02-14 — classification: No Action Indicated (NAI), source: FDA, date: February 14, 2020
- [483 - Dr Reddy's Laboratories Limited - 2019-01-15](https://www.keypedia.com/records/483/dr-reddys-laboratories-limited/2e7927af-43da-467b-a233-11f994f3be46) — source: FDA, date: January 15, 2019
- [FDA Inspection 1076343 - Dr Reddy's Laboratories Limited - 2019-01-15](https://www.keypedia.com/records/fda_inspections/dr-reddys-laboratories-limited/0cb8d080-2ab0-48b3-8bdc-579a22606a53) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 15, 2019
- [483 - Dr Reddy's Laboratories Limited - 2017-06-16](https://www.keypedia.com/records/483/dr-reddys-laboratories-limited/f121236b-9d38-4d62-b093-fae5ecfe15e4) — source: FDA, date: June 16, 2017
- [FDA Inspection 1018229 - Dr Reddy's Laboratories Limited - 2017-06-16](https://www.keypedia.com/records/fda_inspections/dr-reddys-laboratories-limited/15955813-667e-4124-abeb-b472c026e162) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 16, 2017
- FDA Inspection 904970 - Dr Reddy's Laboratories Limited - 2014-11-14 — classification: No Action Indicated (NAI), source: FDA, date: November 14, 2014

## Related Companies

- [Takeda Pharmaceutical Company Limited](https://www.keypedia.com/companies/takeda-pharmaceutical-company-limited/185c125c-128f-47be-ab1b-e1d5324bcc21)
- [Dr. Reddy's Laboratories Ltd.](https://www.keypedia.com/companies/dr-reddys-laboratories-ltd/5a4c4806-5444-4838-9cda-0b0da2f42221)
- [Strides Pharma Science Limited](https://www.keypedia.com/companies/strides-pharma-science-limited/fbdc3ce9-e3c5-4667-86ce-77b376a00100)
- [Mankind Pharma Limited](https://www.keypedia.com/companies/mankind-pharma-limited/448ddf49-4ff4-4a2b-8444-e8cc23677777)
- [Centaur Pharmaceuticals Private Ltd.](https://www.keypedia.com/companies/centaur-pharmaceuticals-private-ltd/65d235da-0400-49d7-acff-38fe013fc5b4)
- [PharmaGend Global Medical Services Pte. Ltd.](https://www.keypedia.com/companies/pharmagend-global-medical-services-pte-ltd/a4dcdf70-101c-46bc-94ab-ddb8956f44a4)
- [I 3 PHARMACEUTICALS, LLC](https://www.keypedia.com/companies/i-3-pharmaceuticals-llc/020702e4-1539-47b8-87d9-725035cecbfe)
- [Intas Pharmaceuticals Limited](https://www.keypedia.com/companies/intas-pharmaceuticals-limited/0db00702-d7f6-4a8b-87d1-1b32ac236cc8)
- [Actavis Laboratories FL, Inc.](https://www.keypedia.com/companies/actavis-laboratories-fl-inc/6c959344-9e81-4c3c-9e6d-580e25151c7d)
- [Strides Pharma, Inc.](https://www.keypedia.com/companies/strides-pharma-inc/e9e4da51-c260-486c-8969-86d64b9b36af)

## Related Officers

- [Account Director](https://www.keypedia.com/people/stacie-a-woods/75a78a01-422e-4c6a-b7ac-b858354264ae)
- [Lata C. Mathew](https://www.keypedia.com/people/lata-c-mathew/0610a0ef-dcc5-43e7-ab74-2ac54d758beb)
- [Compliance Officer](https://www.keypedia.com/people/rumany-c-penn/021eb1e0-8de0-403f-9596-3e76624b2e5a)
- [Research Specialist II](https://www.keypedia.com/people/justin-a-boyd/796c9c9d-02db-486c-bdca-cc259066a0e2)
- [Nibin Varghese](https://www.keypedia.com/people/nibin-varghese/43e17f63-2c1f-4d46-b26f-dc8ac8885438)
